ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 98

$616K Total Retail Price of All Prescriptions

Rank: 20 out of 98

494 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

4% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 34.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 471 373 1 2
LISINOPRIL 447 294 2 3
OMEPRAZOLE 431 236 3 6
AMLODIPINE BESYLATE 381 304 4 7
OXYCODONE-ACETAMINOPHEN 372 130 S2 5 78
FUROSEMIDE 325 260 6 4
LEVOTHYROXINE SODIUM 319 250 7 5
WARFARIN SODIUM 310 256 8 1
TRAZODONE HCL 300 226 9 9
METFORMIN HCL 285 237 10 15
CITALOPRAM HBR 265 174 11 10
METOPROLOL TARTRATE 248 202 12 8
MIRTAZAPINE 191 170 13 11
QUETIAPINE FUMARATE 180 140 14 23
DONEPEZIL HCL 172 160 15 12
TRAMADOL HCL 170 95 16 26
PANTOPRAZOLE SODIUM 164 144 17 42
ATORVASTATIN CALCIUM 161 138 18 20
NAMENDA 156 142 19 18
GABAPENTIN 154 114 20 13
METOPROLOL SUCCINATE 153 137 21 16
POTASSIUM CHLORIDE 148 123 22 21
LIDODERM 130 123 23 29
HYDROCHLOROTHIAZIDE 128 86 24 17
ZOLPIDEM TARTRATE 123 62 25 90
LANTUS 100 59 26 28
CRESTOR 98 87 27 51
TAMSULOSIN HCL 96 79 28 25
NYSTOP 94 48 29 64
OLANZAPINE 93 76 30 24
ATENOLOL 88 85 31 14
PREDNISONE 86 66 32 31
POLYETHYLENE GLYCOL 3350 85 49 33 33
IPRATROPIUM-ALBUTEROL 85 81 33 45
NYSTATIN 82 31 35 56
SERTRALINE HCL 81 71 36 19
RANITIDINE HCL 80 43 37 35
ADVAIR DISKUS 80 68 37 32
CYCLOBENZAPRINE HCL 79 17 R 39 203
CLOPIDOGREL 78 62 40 50
ALLOPURINOL 78 71 40 43
PRAVASTATIN SODIUM 75 40 42 41
NOVOLOG 73 57 43 54
OXYCODONE HCL 73 36 S2 43 61
ISOSORBIDE MONONITRATE ER 73 72 43 36
DOXAZOSIN MESYLATE 72 37 46 98
LEVETIRACETAM 72 59 46 38
DIVALPROEX SODIUM 71 66 48 22
LOSARTAN POTASSIUM 68 68 49 34
PROAIR HFA 67 29 50 58
TRIAMCINOLONE ACETONIDE 66 15 51 93
SPIRIVA 62 39 52 46
AZITHROMYCIN 61 24 53 104
RISPERIDONE 60 54 54 27
GLIPIZIDE 59 43 55 37
IBUPROFEN 59 27 55 74
OXYBUTYNIN CHLORIDE ER 57 38 57 88
AMITRIPTYLINE HCL 57 24 R 57 167
LEVOFLOXACIN 55 43 59 63
ALENDRONATE SODIUM 54 51 60 30
DOXYCYCLINE HYCLATE 54 31 60 168
DICLOFENAC SODIUM 53 0 62 178
CLOTRIMAZOLE-BETAMETHASONE 52 25 63 115
TRIAMTERENE-HCTZ 51 42 64 111
MECLIZINE HCL 51 32 64 164
DIGOXIN 50 45 66 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.